Concepedia

Author

Massimo Breccia

Sapienza University of RomeORCID

Also Known As

Breccia M., Breccia Massimo, Breccia, Massimo, Luca Maurillo, M Breccia, M. Breccia, Massimo Breccia, on behalf of AIFA Monitoring Registries Group

1K

Publications

17.2K

Citations

59

H-Index

148

Concepts

All Affiliations

Sapienza University of RomeUniversity of BolognaSt. Eugenio HospitalIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Bari Aldo Moro
MB

About

Massimo Breccia is an author at Sapienza University of Rome specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

36

114

3.9K

2

Health Sciences

22

41

1.4K

3

Natural Sciences

3

3

127

4

Nursing

3

3

61

5

Education

1

1

27

Massimo Breccia

×

251

Publications

11.7K

Citations

53

H-Index

YearCitations

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti,

New England Journal of Medicine

2013

1.6K

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes,

New England Journal of Medicine

2019

449

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi,

Journal of Clinical Oncology

2016

375

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti,

Blood

2010

340

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Fabio Efficace, Michele Baccarani, Massimo Breccia,

Blood

2011

252

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia

Gianantonio Rosti, Francesca Palandri, Fausto Castagnetti,

Blood

2009

210

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

NI Noguera, Massimo Breccia, Mariadomenica Divona,

Leukemia

2002

181

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio,

Cancer

2019

144

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Maria Teresa Voso, Susanna Fenu, Roberto Latagliata,

Journal of Clinical Oncology

2013

136

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

Fabio Efficace, Michele Baccarani, Massimo Breccia,

Leukemia

2013

135

Page 1